EPI / CCSG Risk Detection and Outcomes (RDO) Seminars
January 31, 2019
Sean V. Tavtigian, Ph.D.
Professor of Oncological Sciences, University of Utah School of Medicine
Co-Leader, Cancer Control and Population Sciences Program, Huntsman Cancer Institute
Title: "Taming the wild VUS (i.e. Variant of Uncertain Significance)"
January 16, 2019
Jiali Han, Ph.D.
Professor and Chair, Department of Epidemiology, Richard M. Fairbanks School of Public Health
Co-Leader, Cancer Prevention and Control Program, Melvin & Bren Simon Cancer Center, Indiana University
Title: "Melanoma: From Molecular Epidemiology to Network Medicine"
December 12, 2018
Christopher I. Amos, Ph.D.
Associate Director, Quantitative Science; Dan L. Duncan Comprehensive Cancer Center
Director, Institute of Clinical and Translational Medicine, Department of Medicine, Baylor College of Medicine
Title: "Machine Learning to Understand Cancer and Complex Disease Etiology"
November 29, 2018
Neal D. Freedman, Ph.D., M.P.H.
Senior Investigator, National Cancer Institute, Division of Epidemiology & Genetics, Metabolic Epidemiology Branch
Title: "Surprising Increases in the Rates of Premature Mortality in the United States" and
"Opportunities for Research in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial"
October 31, 2018
Philip J. Lupo, Ph.D., M.P.H.
Associate Professor of Pediatrics; Co-Director, Epidemiology Program at Texas Children's Cancer Center and Hematology Centers, Baylor College of Medicine
Title: "Cancer Risk among Children and Adolescents with Birth Defects: A Population-Based and Genomic Assessment"